These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3344592)

  • 1. Biopharmaceutical studies, a key to better toxicology.
    Zbinden G
    Xenobiotica; 1988 Jan; 18 Suppl 1():9-14. PubMed ID: 3344592
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic and kinetic aspects of toxicological studies. 19 May 1987, Paris, France.
    Xenobiotica; 1988 Jan; 18 Suppl 1():1-96. PubMed ID: 3344587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
    Rubio Terrés C; Duque I; Tristán C; Galende I
    Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolomics in toxicology: preclinical and clinical applications.
    Robertson DG; Watkins PB; Reily MD
    Toxicol Sci; 2011 Mar; 120 Suppl 1():S146-70. PubMed ID: 21127352
    [No Abstract]   [Full Text] [Related]  

  • 5. Misinterpretations of results and creation of "artifacts" in studies on developmental toxicity using systems simpler than in vivo systems.
    Neubert D; Blankenburg G; Lewandowski C; Klug S
    Prog Clin Biol Res; 1985; 171():241-66. PubMed ID: 3885246
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of statistics when examining lifetime studies in rodents to detect carcinogenicity.
    Salsburg DS
    J Toxicol Environ Health; 1977 Nov; 3(4):611-28. PubMed ID: 592429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embracing complexity in drug discovery.
    Gund P; Maliski E; Brown F
    Curr Opin Drug Discov Devel; 2007 May; 10(3):252-3. PubMed ID: 17554850
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety assessment of drug residues.
    Jackson BA
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1141-4. PubMed ID: 6894293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological methods in toxicology: general concepts.
    Zbinden G
    Pharmacol Ther B; 1979; 5(1-3):3-6. PubMed ID: 386372
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety evaluation to support First-In-Man investigations II: toxicology studies.
    Baldrick P
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):237-43. PubMed ID: 18501490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation.
    Chapman KL; Holzgrefe H; Black LE; Brown M; Chellman G; Copeman C; Couch J; Creton S; Gehen S; Hoberman A; Kinter LB; Madden S; Mattis C; Stemple HA; Wilson S
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):88-103. PubMed ID: 23524271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
    Claude JR; Claude N
    Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomization of animals by computer program for toxicity studies.
    Martin RA; Daly A; DiFonzo CJ; de la Iglesia FA
    J Environ Pathol Toxicol Oncol; 1986; 6(5-6):143-52. PubMed ID: 3783436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluations of organ system development in juvenile toxicology testing.
    Robinson K
    Reprod Toxicol; 2008 Sep; 26(1):51-3. PubMed ID: 18595655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control, drug preparation and dosage in the designing of experiments (author's transl)].
    Chen X
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):335-8. PubMed ID: 6796231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.